1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Body Weight

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Body Weight in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mårtensson, L; Nilsson, R; Ohlsson, T; Senter, P; Sjögren, HO; Strand, SE; Tennvall, J; Wang, Z	1
DeNardo, GL; DeNardo, SJ; Fand, I; Kroger, LA; Kukis, DL; Meares, CF; Miers, LA; Renn, O; Salako, Q; Shen, S	1

Other Studies

2 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Body Weight

Article	Year
Determining maximal tolerable dose of the monoclonal antibody BR96 labeled with 90Y or 177Lu in rats: establishment of a syngeneic tumor model to evaluate means to improve radioimmunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Oct-01, Volume: 11, Issue:19 Pt 2 Topics: Animals; Antibodies, Monoclonal; Biotin; Body Weight; Brain; Chelating Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Heterocyclic Compounds, 1-Ring; Leukocytes; Lutetium; Maximum Tolerated Dose; Platelet Count; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rats; Time Factors; Yttrium Radioisotopes	2005
Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3). Cancer, 1994, Feb-01, Volume: 73, Issue:3 Suppl Topics: Animals; Blood Cell Count; Blood Platelets; Body Weight; Bone Marrow; Chelating Agents; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Mice; Mice, Inbred BALB C; Mucins; Pentetic Acid; Radioimmunotherapy; Radiotherapy Dosage; Yttrium Radioisotopes	1994

Article

Year

Determining maximal tolerable dose of the monoclonal antibody BR96 labeled with 90Y or 177Lu in rats: establishment of a syngeneic tumor model to evaluate means to improve radioimmunotherapy.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Oct-01, Volume: 11, Issue:19 Pt 2

Topics: Animals; Antibodies, Monoclonal; Biotin; Body Weight; Brain; Chelating Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Heterocyclic Compounds, 1-Ring; Leukocytes; Lutetium; Maximum Tolerated Dose; Platelet Count; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rats; Time Factors; Yttrium Radioisotopes

2005

Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3).

Cancer, 1994, Feb-01, Volume: 73, Issue:3 Suppl

Topics: Animals; Blood Cell Count; Blood Platelets; Body Weight; Bone Marrow; Chelating Agents; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Mice; Mice, Inbred BALB C; Mucins; Pentetic Acid; Radioimmunotherapy; Radiotherapy Dosage; Yttrium Radioisotopes

1994